Literature DB >> 20203147

Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.

Kinga G Blecharz1, Aiden Haghikia, Mariusz Stasiolek, Niels Kruse, Detlev Drenckhahn, Ralf Gold, Norbert Roewer, Andrew Chan, Carola Y Förster.   

Abstract

Compromised blood-brain barrier integrity is a major hallmark of active multiple sclerosis (MS). Alterations in brain endothelial tight junction protein and gene expression occur early during neuroinflammation but there is little known about the underlying mechanisms. In this study, we analysed barrier compromising effects of sera from MS patients and barrier restoring effects of glucocorticoids on blood-brain barrier integrity in vitro. cEND murine brain microvascular endothelial cell monolayers were incubated with sera from patients in active phase of disease or in relapse. Data were compared with effects of the glucocorticoid dexamethasone alone or in combination with MS sera on barrier integrity. Tight junction protein levels and gene expression were evaluated concomitant with barrier integrity. We reveal downregulation of claudin-5 and occludin protein and mRNA and an accompanying upregulation in expression of matrix metalloproteinase MMP-9 after incubation with serum from active disease and remission and also a minor reconstitution of barrier functions related to dexamethasone treatment. Moreover, we for the first time describe downregulation of claudin-5 and occludin protein after incubation of cEND cells with sera from patients in remission phase of MS. Our findings reveal direct and differential effects of MS sera on blood-brain barrier integrity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203147     DOI: 10.1177/1352458509358189

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  22 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 2.  Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.

Authors:  Noor Al-Dasooqi; Hannah R Wardill; Rachel J Gibson
Journal:  Pathol Oncol Res       Date:  2014-01-15       Impact factor: 3.201

Review 3.  Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.

Authors:  Chris Greene; Matthew Campbell
Journal:  Tissue Barriers       Date:  2016-01-08

4.  Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein.

Authors:  Christopher D Hue; Frances S Cho; Siqi Cao; Cameron R Dale Bass; David F Meaney; Barclay Morrison
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

5.  Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.

Authors:  Jonas Protze; Miriam Eichner; Anna Piontek; Stefan Dinter; Jan Rossa; Kinga Grażyna Blecharz; Peter Vajkoczy; Joerg Piontek; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2014-10-24       Impact factor: 9.261

Review 6.  Occludin: one protein, many forms.

Authors:  Philip M Cummins
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

7.  Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.

Authors:  Justin T Easley; Joel W Nelson; Rachel E Mellas; Salah Sommakia; Chunhua Wu; Bryan Trump; Olga J Baker
Journal:  J Rheum Dis Treat       Date:  2015-12-17

Review 8.  Development, maintenance and disruption of the blood-brain barrier.

Authors:  Birgit Obermeier; Richard Daneman; Richard M Ransohoff
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

9.  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.

Authors:  Kinga G Blecharz; Dietmar Frey; Tobias Schenkel; Vincent Prinz; Gloria Bedini; Susanne M Krug; Marcus Czabanka; Josephin Wagner; Michael Fromm; Anna Bersano; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

10.  Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.

Authors:  Malgorzata Burek; Ellaine Salvador; Carola Y Förster
Journal:  J Vis Exp       Date:  2012-08-29       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.